We have studied the effects of recombinant human thrombopoietin (TPO; mpl ligand) on the proliferation of human primitive hematopoietic progenitors in vitro. CD34+ cells were enriched for cell-cycle-dormant primitive progenitors by separation on the basis of expression of c-kit and CD38.
R tories, using different strategies, purified thrombopoietin (TPO), the ligand for c-mpl receptor, and cloned its It was observed that TPO supports the proliferation of megakaryocytic progenitors and their differentiation into large polyploid, platelet-producing The c-mpl-deficient mice showed a dramatic decrease in the numbers of platelets and megakryocytes and increased levels of circulating TPO." Administration of TPO into normal mice stimulated megakaryopoiesis and increased the levels of circulating platelets.'.' Blood levels of c-mpl ligand were inversely related to circulating platelet counts.6-' On the basis of these evidences, TPO is thought to be the physiological regulator of megakaryocytopoiesis and thrombopoiesis in vivo.
The proto-oncogene v-mpl was originally identified in myeloproliferative leukemia virus.'* Myeloproliferative leukemia virus caused multilineage murine leukemias, involving erythroid, granulocytic, monocytic, megakaryocytic, and mast-cell lineage^.'^.'^ In addition, the c-mpl transcript was present in human CD34+CD38-cells, which are highly enriched for primitive progenitor^.'^ These observations suggested the possibility that TPO may be involved in the proliferation of early hematopoietic cells. Recently, Kaushansky et all6 reported that TPO accelerates red blood cell recovery in myelosuppressed mice. We observed that TPO enhances human erythroid proliferation in culture." Ku et al," in our laboratory, observed that TPO interacts with Steel factor (SF) or interleukin-3 (IL-3) to support the formation of multiple types of hematopoietic colonies, including multilineage colonies from a highly purified population of hematopoietic progenitors of mice.
We have now extended our cell culture studies to elucidate further the precise biological effects of TPO on human hematopoiesis using bone marrow cells that were highly enriched for primitive progenitors. We provide data here that TPO synergizes with SF and/or IL-3 in support of formation of multilineage colonies, granulocyte/macrophage colonies, and erythroid colonies. These results indicate that TPO, in addition to its effects on megakaryopoiesis and thrombopoiesis, has an ability to stimulate proliferation of human multipotential progenitors.
MATERIALS AND METHODS
Purified recombinant human TPO and recombinant human granulocyte colony-stimulating factor (G-CSF) were pre- pared by the Cytokine Production Group of Kirin Brewery (Maebashi, J a~a n ) .~.~ Recombinant yeast-derived human SF was provided by Dr S. Lyman (Immunex, Seattle, WA). Recombinant human IL-3 with a specific activity of 1.86 X lo6 U/mg and recombinant human IL-11 were supplied by the Genetics Institute (Cambridge, MA). Purified recombinant human IL-6 was a gift from Dr M. Naruto of Toray Industries (Yokohama, Japan). Recombinant human erythropoietin (Epo) was provided by Dr Fu-Kuen Lin of Amgen (Thousand Oaks, CA). Unless otherwise specified, the concentrations of growth factors used were as follows: TPO, 50 ng/mL; IL-3, 100 U/ mL; SF, 100 ng/mL; IL-6, 100 ng/mL; IL-11, 100 ng/mL; G-CSF, 100 ng/mL; and Epo, 2 U/mL.
Bone marrow cells were aspirated from the posterior iliac crest of healthy adult volunteers after informed consent. helium neon laser to recognize only FITCpositive cells. Low to medium forward scatter and low side scatter, as well as negative PI fluorescence gates, were also used. For study of megakaryocyte colony formation, the samples were sorted again using Normal-R mode to obtain purer CD34+ cell population. For use in the remainder of studies enriched CD34' cells were further stained with phycoerythrin (PE)-conjugated anti-c-kit (Amac, Westbrook, ME) and biotin-conjugated anti-CD38 for 30 to 40 minutes at 4°C. Cells were then washed twice and stained with streptavidin labeled with allophycocyanin (APC; Caltag Laboratories, San Francisco, CA) for 20 minutes at 4°C. After the addition of PI at a concentration of 1 pglmL, cells were washed twice and resuspended in PBSIDNaselAz. The appropriate isotype controls were used to identify background staining. Forward and orthogonal light scatter signals, as well as specific fluorescence of FITC, PE, APC, and PI excited at 488 nm and 633 nm, were used to establish sort windows.
Cells were separated into fractions expressing positive CD34, low and high levels of c-kit, low or negative levels of CD38, and high levels of CD38, respectively. Data acquisition and analysis was performed with CellQuest software (Becton Dickinson Immunocytometry Systems). Single-cell sorting was performed using the Automated Cell Deposition Unit (ACDU) with Clone-Cyt software (Becton Dickinson Immunocytometry Systems).
Clonal cell culture was performed in 35-mm Falcon suspension culture dishes (Becton Dickinson Labware, Lincoln Park, NJ). In serum-deprived culture, 1 mL of the cuIture mixture contained 100 to 200 sorted cells, 2% deionized crystallized bovine serum albumin (BSA; Sigma), 300 figlmL fully iron-saturated human transferrin (98% pure; Sigma), 10 pg/mL soybean lecithin (Sigma), 6 pglmL cholesterol (Sigma), 1 X mol/L sodium selenite (Sigma), 10 pg/mL insulin (Sigma), 1.2% 1,500-centipoise methylcellulose (Shinetsu Chemical, Tokyo, Japan), and designated cytokine~.'~.~' In serum-supplemented culture, crystallized BSA, transferrin, cholesterol, lecithin, selenite, and insulin were replaced by 30% FBS and 1% deionized fraction V BSA (Sigma). Serumdeprived cultures were incubated at 37°C in a humidified atmosphere with 5% C02/5% 02/90% N,, and serum-supplemented cultures were in a humidified atmosphere with 5% C02/95% air, respectively. On day 14 of incubation, colonies were scored on an inverted microscope using the criteria described previously.** Colony types are abbreviated as follows: GM, granulocyte andfor macrophage colonies; E, erythroid colonies; Meg, megakaryocyte colonies; E-mix, mixed colonies containing erythroid and myeloid cells and megakaryocytes.
Serum-deprived liquid suspension cultures were performed in 96-well plates. Cultures consisted of single or 100 cells per well in AMEM, 2% deionized crystallized BSA (Sigma), 300 pg/mL fully iron-saturated human transferrin (98% pure; Sigma), 10 pg/mL soybean lecithin (Sigma), 6 yg/mL cholesterol (Sigma), 1 X molL sodium selenite (Sigma), and 10 pg/mL insulin (Sigma), with or without designated cytokines. Incubation was performed at 37°C in a humidified atmosphere with 5% C02/5% O2/90% N2. After 7 days of primary suspension cultures, the cells were washed twice in AMEM and plated in secondary methylcellulose cultures supplemented with 30% FBS, 1% deionized fraction V BSA, IL-3, SF, IL-6, and Epo. Incubation was for 14 days at 37°C in a humidified atmosphere with 5% C0?/95% air. Statistical analysis. Student's t test was used to determine the statistical significance of the data.
RESULTS
Effects of TPO on megakaryocyte colony formation from CD34' cells. First, we examined dose-effects of TPO on the formation of Meg colonies from CD34' cells in serumdeprived culture. As shown in Fig 1, the number of Meg colonies reached a plateau at 10 to 50 ng/mL TPO. Based on this observation, we used 50 ng/mL in the subsequent studies.
Expression qf c-kit a n d CD38 on CD34' cells of bone marrow. Earlier, we documented that the primitive murine hematopoietic progenitors in cell-cycle dormancy are enriched in the c-kip" population." We subsequently observed that human bone marrow cells that are capable of longterm engraftment are in the CD34'lc-kiP"" populati~n.*~~*~ A number of investigators have reported that, of the progenitors in CD34+ cell population, CD38"ed0" cells are more primitive than CD38h'gh cell^.^^-^' Therefore, we examined the combined expression of c-kit and CD38 in CD34' cells to enrich further human primitive progenitors in cell-cycle dormancy. Figure 2 shows a typical flow cytometric analysis of bone marrow cells stained with CD34-HTC, c-kit-PE and CD38-APC. In 10 bone marrow samples, 1.8% (SD, -+ 1.1%) of the nonadherent light-density mononuclear cells expressed CD34. Within the CD34+ cell population, the percentages (mean t SD) of each fraction are as follows: ckir"'6/CD38"e6""", 1 1.5 ? 8.0; ~-kit"~g/CD38~'~~, 41.6 t 12.9; c-kiP""/CD38""~''"", 4.9 ? 1.5; ~-kir'""/CD38~'~, 20.7 ? 6.3; ~-kit'"~~/CD38"~~'''~, 2.6 t 1.2; and ~-k i t h '~~/ C D 3 8~'~~, 18.8 t 9.1. As previously rep0rted,2','~,~'.~~ the expression of c-kit and CD38 correlated with differentiation and activation of the CD34' cells, resulting in few CD34+/~-kith'~~/CD38"~~"~'' cells.
Colony formation from CD38"'x''''"' a n d CD38hiK" fractions 
CDJS-APC
of CD34+/c-kit'""' cells supported by IL-3, SF, und TPO as ble 1. In agreement with previously reported single agents und in combinations. We tested colony for-CD38"cg'""" cells yielded fewer colonies than CD3ShLgh cells mation from CD34+lc-kit'"" cells that were further separated under both culture conditions. In cultures of the CD38""E""" on the basis of CD38 expression in serum-deprived and secell population, TPO, SF, and IL-3 as single agents failed rum-supplemented cultures. The results are presented in Tato support colony formation or supported formation of only One hundred cells were plated per well in serum-deprived media containing designated cytokines and incubated for 7 days in 5% OJ5% C0,I 90% N, . Cells in each well were washed twice with AMEM and replated in clonal culture containing 30% FBS, 1% BSA, IL-3, SF, IL-6, and Epo. Incubation was performed for 14 days in 5% COJ95% air. Data represent the mean 2 SD of colonies per plate in quadruplicate suspension cultures. Similar results were obtained in 3 additional experiments.
a few erythroid colonies. However, combinations of these cytokines, particularly the combination of TPO, SF, and IL-3, showed significant synergy in support of colony formation. In contrast to CD38"e9""" population, the effects of these cytokines on colony formation from CD38h'gh population were merely additive. Meg colony formation was not seen in either population. These observations indicated that TPO is an early-acting cytokine capable of supporting proliferation of primitive hematopoietic progenitors. CD34+/~-kiP'~~l CD38"""'"" and CD34+l~-kiP'~~hlCD38~'~~ populations were also analyzed for colony formation in serum-supplemnted culture supported by a combination of IL-3, SF, and TPO. The frequencies of colony-forming cells in 200 cells were 1 ? 1 and 38 t 5, respectively. Although the CD34+lc-kiPgh cell population contains a number of colony-forming cells, the primitive cells that have capability for long-term engraftment are only in the CD34+lc-kil"" p~p u l a t i o n .~~~~~ From these findings, subsequent studies were performed using the CD34+/c-Kitl0" population.
Effects of TPO on production of colony-jurming cells in suspension culture. We also used suspension culture in order to confirm the effects of TPO on primitive hematopoietic progenitors. In this experiment, the two cell populations were incubated with designated cytokines in serum-deprived suspension culture for 7 days and were assayed for colony formation in clonal culture containing IL-3, SF, IL-6, and Epo. As presented in Table 2 , there was significant synergy in support of proliferation of colony-forming cells among TPO, SF, and IL-3 in cultures of CD38""g"0" population. The combination of TPO, SF, and IL-3 provided maximal stimulation for production of colony-forming cells from CD38"e9"0" population. In contrast, no significant synergy was found with these cytokines when the CD38h'gh cell population was studied. These observations were in agreement with the data presented in Table 1 and indicated again that TPO is an early-acting cytokine capable of stimulating primitive progenitors. As shown in Fig 3, maximal stimulation of colony formation was seen with 10 to 50 ng/mL of TPO. Throughout the concentrations tested, the combination of TPO and IL-3 enhanced production of erythroid colonyforming cells, whereas SF plus TPO enhanced primarily production of GM colony-forming cells. Suspension culture of CD38"'@"" cell populations yielded more colony-forming cells than the CD3ghlgh cell population, although the former contained fewer colony-forming cells ( Table 1) . These observations further supported the primitive nature of the progenitors in the CD38""@"" cell population.
To determine if the activity of TPO was direct, we sorted the cells using ACDU and analyzed proliferation from single cells. All wells were inspected carefully by an inverted microscope 24 hours after the single cells were deposited individually into the wells of 96-well plates. We were able to detect 1 celVwell in approximately 60% to 70% of the wells. After 7 days of suspension culture, we scored the number of wells containing more than eight cells. As presented in Table 3 , individual TPO, SF, or IL-3 could not support proliferation from single cells, but combinations of TPO, SF, andor IL-3 were capable of supporting the clonal proliferation of CD34'lc-kil""l CD38"eE""" cells. A combination of TPO, SF, and IL-3 supported more clonal proliferation than any other two-factor combinations. To ascertain accurately the proliferative and differentiation potentials of the cells in each well, the content of each well was individually replated into secondary clonal culture containing IL-3, SF, IL-6, and Epo. The results of the replating studies of the clones are presented in Table 4 . The replating efficiencies were 84% in experiment 1 and 83% in experiment 2. Furthermore, high percentages of the cells proved to be colony-forming cells. Although the majority of the colonies were GM colonies or erythroid colonies, there were some multilineage colonies expressing both erythroid and myeloid lineages. These observations strongly Direct effects of TPO.
For Table 2 .
After incubation for 7 days, cells were washed twice with AMEM and incubated in methylcellulose culture containing 30% FBS, 1% BSA, IL-3, SF, 11-6, and Epo for 14 more days in 5% C02/95% air atmo- indicated that TPO directly acts on the single CD34'Ic-kit'""I CD3tYF"""' cells in synergy with SF and/or IL-3.
Comparison with orher early-acting cytokines. Earlier, our laboratory reported that IL-6, IL-I 1, and G-CSF are involved in triggering of the cell-cycle-dormant multipotential progenitors in synergy with SF or IL-3.""" We have now shown that TPO also has direct effects on primitive progenitors in synergy with SF andor IL-3. According, we compared the activity of TPO with that of IL-6, IL-I I , or G-CSF. CD34+/~-kit'"~/CD38"'~"~ cells were incubated in suspension culture with each early-acting factor in the presence of SF, IL-3, or a combination of SF and IL-3 for 7 days and assayed for colony formation. The results are shown in Table 5 . All early-acting cytokines synergized with both SF and IL-3 to support the production of total colony-forming cells; however, TPO was the most effective. TPO enhanced generation of erythroid, GM, and some multilineage progenitors. The combination of TPO, SF, and IL-3 showed the maximal stimulation of progenitor production.
DISCUSSION
In this study, we have examined the effects of TPO in combinations with SF and/or IL-3 on the growth of human primitive hematopoietic progenitors. We used CD34+/ck;tbW bone marrow cells, which were further separated on the basis of the expression of CD38. CD34'lc-kir'""l CD38"eg'/'"w cells are thought to be enriched for primitive progenitors, because both CD34'lc-kit'"" and CD34'/ CD38"ea''"W populations are capable of long-term engraftment in fetal ~heep'~.''.~~ and are dormant in cell cyle.'^^""^" The data presented here demonstrate that TPO, in synergy with SF and/or IL-3, stimulates the proliferation of CD34'/~-kit""/CD38"~~''~~ cells. These observations on human primitive progenitors are in agreement with our recent observations on murine progenitors.IK Initial studies of v-mpl indicated that the viral gene induces a pan-myeloid proliferative Methia et all5 reported that although c-mpl was expressed by both CD38' and CD38-of CD34' bone marrow cells, the signal obtained with CD34'CD38-population was 10 to 50 times more intense than that with CD34'CD38' population. Our observation that the synergistic effects of TPO with SF and/or IL-3 were found mainly in CD38"ee"nw fraction (Table 2) are consistent with these molecular events. The single-cell proliferation studies using ACDU clearly demonstrated the direct effects of TPO on human primitive multipotential progenitors. While TPO appears to be the physiological regulator of megakaryocytopoiesis and thrombopoiesis, these results indicate that TPO also has the capability to function as an early-acting cytokine Table 3 were replated in clonal culture containing IL-3, SF, IL-6, and Epo. Incubation was performed for 14 days in a humidified atmosphere of 5% COJ95% air.
regulating proliferation of multipotential progenitors of human bone marrow.
Earlier, we have proposed that early-acting cytokines are grouped together based on their functional similarities.38 In this model, IL-6, IL-1 1, and G-CSF are members of a group that synergizes with SF or IL-3 in support of the proliferation of primitive hematopoietic progenitor^.^'"^ Therefore, we compared the effects of TPO with those of IL-6, IL-1 1, and G-CSF using the ~-kil""/CD38"~"" population in serum-deprived culture. In synergy with SF, TPO supported production of more progenitors than IL-6, IL-11, or G-CSF. While statistically less significant, TPO showed stronger synergy than IL-6, IL-11, or G-CSF with IL-3 or a combination of SF and IL-3 in support of progenitor production. There is significant current interest directed at in vitro amplification of stem cells and progenitors. The cytokines being tested for this purpose include those used in our study and other early-acting cytokines such as GM-CSF, IL-1, and ligand for flt3/flk2. We recently observed that IL-3 and IL-1 (both a and p) significantly inhibit the survival in vitro of murine hematopoietic stem cells with the ability to provide long-term reconstitution in lethally irradiated mice.4' Berardi et a14' reported that cell-cycle-dormant putative human hematopoietic stem cells express c-kit and c-mpl mRNA, but not the common chain shared by IL-3 and GM-CSF receptors. These observations and our observations of the strong synergy between TPO and SF in vitro suggest that a combination of TPO and SF may be the best cytokine combination One hundred CD34C/c-kil'"w/CD38"oo~aw cells were incubated in suspension culture in serum-deprived media containing a test cytokine and either SF, IL-3, or SF plus IL-3 under 5% OJ5% COJ90% N2 condition. After 7 days of culture, cells were washed twice in AMEM and recultured in methylcellulose containing 30% FBS, 1% BSA, IL-3, SF, IL-6, and Epo for 14 days under 5% COJ95% air condition. Data represent the mean 
